The DOI matches its Crossref record; 235 of the 235 references it cites were found in a registry or an index.
Risk factors for progression of age‐related macular degeneration
Open accessAbstract
Purpose: Age‐related macular degeneration (AMD) is a degenerative disease of the macula, often leading to progressive vision loss. The rate of disease progression can vary among individuals and has been associated with multiple risk factors. In this review, we provide an overview of the current literature investigating phenotypic, demographic, environmental, genetic, and molecular risk factors, and propose the most consistently identified risk factors for disease progression in AMD based on these studies. Finally, we describe the potential use of these risk factors for personalised healthcare. Recent findings: While phenotypic risk factors such as drusen and pigment abnormalities become more important to predict disease progression during the course of the disease, demographic, environmental, genetic and molecular risk factors are more valuable at earlier disease stages. Demographic and environmental risk factors such as age and smoking are consistently reported to be related to disease progression, while other factors such as sex, body mass index (BMI) and education are less often associated. Of all known AMD variants, variants that are most consistently reported with disease progression are rs10922109 and rs570618 in CFH , rs116503776 in C2/CFB/SKIV2L , rs3750846 in ARMS2/HTRA1 and rs2230199 in C3 . However, it seems likely that other AMD variants also contribute to disease progression but to a lesser extent. Rare variants have probably a large effect on disease progression in highly affected families. Furthermore, current prediction models do not include molecular risk factors, while these factors can be measured accurately in the blood. Possible promising molecular risk factors are High‐Density Lipoprotein Cholesterol (HDL‐C), Docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), zeaxanthin and lutein. Summary: Phenotypic, demographic, environmental, genetic and molecular risk factors can be combined in prediction models to predict disease progression, but the selection of the proper risk factors for personalised risk prediction will differ among individuals and is dependent on their current disease stage. Future prediction models should include a wider set of genetic variants to determine the genetic risk more accurately, and rare variants should be taken into account in highly affected families. In addition, adding molecular factors in prediction models may lead to preventive strategies and personalised advice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–235 of 235
Apolipoprotein E Isoforms and AMD
Toops, K. A., Tan, L. X., & Lakkaraju, A. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-17121-0_1 · Cited by 41
Associations of Alzheimer rsquo s disease with macular degeneration
Parnetti, L. (2016) · Frontiers in Bioscience-Elite · doi:10.2741/e794 · Cited by 41
Ngai, L.-Y., Stocks, N. P., Sparrow, J. M., Patel, R., Rumley, A., Lowe, G. D. O., Smith, G. D., & Ben‐Shlomo, Y. (2011) · Eye · doi:10.1038/eye.2011.56 · Cited by 40
Yip, J. L. Y., Khawaja, A. P., Chan, M. P. Y., Broadway, D. C., Pető, T., Tufail, A., Luben, R., Hayat, S. A., Bhaniani, A., Wareham, N. J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132565 · Cited by 39
Taylor, R. L., Poulter, J. A., Downes, S. M., McKibbin, M., Khan, K. N., Inglehearn, C. F., Webster, A. R., Hardcastle, A. J., Michaelides, M., Bishop, P. N., et al. (2019) · Ophthalmology · doi:10.1016/j.ophtha.2019.03.013 · Cited by 36
Susceptibility Genes and Progression in Age-Related Maculopathy: A Study of Single Eyes
Farwick, A., Wellmann, J., Stoll, M., Pauleikhoff, D., & Hense, H. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-3953 · Cited by 34
Freeman, E. E., Muñoz, B. E., Bressler, S. B., & West, S. K. (2005) · Ophthalmic Epidemiology · doi:10.1080/09286580490907779 · Cited by 34
Farinha, C., Cachulo, M. L., Alves, D., Pires, I., Marques, J. P., Barreto, P., Nunes, S. G., Costa, J. C., Martins, A., Sobral, I., et al. (2019) · Ophthalmic Research · doi:10.1159/000496393 · Cited by 32
Physical Activity and the 15-Year Incidence of Age-Related Macular Degeneration
Gopinath, B., Liew, G., Burlutsky, G., & Mitchell, P. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-15575 · Cited by 31
Serra, R., Coscas, F., Boulet, J. F., Cabral, D., Lupidi, M., COSCAS, G. J., & Souied, E. H. (2019) · Retina · doi:10.1097/iae.0000000000002604 · Cited by 31
Connolly, E., Rhatigan, M., O’Halloran, A. M., Muldrew, K. A., Chakravarthy, U., Cahill, M. T., Kenny, R. A., & Doyle, S. (2018) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2017-311673 · Cited by 30
Dietzel, M., Pauleikhoff, D., Arning, A., Heimes, B., Lommatzsch, A. P., Stoll, M., & Hense, H. (2014) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-014-2690-7 · Cited by 29
Lechanteur, Y. T. E., van de Ven, J. P. H., Smailhodzic, D., Boon, C. J. F., Klevering, B. J., Fauser, S., Groenewoud, J. M. M., van der Wilt, G. J., den Hollander, A. I., & Hoyng, C. B. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-7731 · Cited by 29
Self-citationRisk Factors for Progression of Early Age-Related Macular Degeneration in Koreans
Shim, S. H., Kim, S., Bae, J. H., Yu, H. G., & Song, S. J. (2016) · Ophthalmic Epidemiology · doi:10.3109/09286586.2015.1129425 · Cited by 29
The unconventional secretion of ARMS2
Körtvely, E., Hauck, S. M., Behler, J., Ho, N., & Ueffing, M. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw162 · Cited by 29
Sardell, R. J., Persad, P. J., Pan, S. S., Whitehead, P. G., Adams, L. D., Laux, R. A., Fortun, J. A., Brantley, M. A., Kovach, J. L., Schwartz, S. G., et al. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-19519 · Cited by 28
Brader, H. S., Ying, G., Martin, E. R., & Maguire, M. G. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2013.01.049 · Cited by 27
Dietary intake of α-linolenic acid and risk of age-related macular degeneration ,
Wu, J., Cho, E., Giovannucci, E. L., ROSNER, B. A., Sastry, S. M., Schaumberg, D. A., & Willett, W. C. (2017) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.143453 · Cited by 25
Oxidized Low-density Lipoprotein and the Incidence of Age-related Macular Degeneration
Klein, R., Lee, K. E., Tsai, M. Y., Cruickshanks, K. J., Gangnon, R. E., & Klein, R. (2018) · Ophthalmology · doi:10.1016/j.ophtha.2018.12.026 · Cited by 25
Kersten, E., Geerlings, M. J., den Hollander, A. I., de Jong, E. K., Fauser, S., Pető, T., & Hoyng, C. B. (2017) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2017.3195 · Cited by 24
Self-citationAdvanced imaging for the diagnosis of age‐related macular degeneration: a case vignettes study
Ly, A., Nivison‐Smith, L., Zangerl, B., Assaad, N. N., & Kalloniatis, M. (2017) · Clinical and Experimental Optometry · doi:10.1111/cxo.12607 · Cited by 23
Age-Related Macular Degeneration in Chronic Kidney Disease: A Meta-Analysis of Observational Studies
Chen, Y.-J., Yeung, L., Sun, C., Huang, C.-C., Chen, K.-S., & Lu, Y. (2018) · American Journal of Nephrology · doi:10.1159/000493924 · Cited by 23
Heesterbeek, T. J., de Jong, E. K., Acar, İ. E., Groenewoud, J. M. M., Liefers, B. J., Sánchez, C. I., Pető, T., Hoyng, C. B., Pauleikhoff, D., Hense, H. W., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-43144-3 · Cited by 23
Self-citationSakurada, Y., Sugiyama, A., Kikushima, W., Yoneyama, S., Tanabe, N., Matsubara, M., & Iijima, H. (2019) · Japanese Journal of Ophthalmology · doi:10.1007/s10384-019-00680-9 · Cited by 23
Highly Penetrant Alleles in Age-Related Macular DegenerationPreprint
den Hollander, A. I., & de Jong, E. K. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a017202 · Cited by 22
Evidence for an Association between Macular Degeneration and Thyroid Cancer in the Aged Population
Lin, S.-Y., Hsu, W., Lin, C., Lin, C., Lin, J.-M., Chang, Y.-L., Hsu, C. Y., & Kao, C. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15050902 · Cited by 21
The Human Fetal Retinal Pigment Epithelium: A Target Tissue for Thyroid Hormones
Duncan, K. G., Bailey, K. R., Baxter, J. D., & Schwartz, D. M. (1999) · Ophthalmic Research · doi:10.1159/000055564 · Cited by 20
Wang, I., Lin, H., Wan, L., Lin, C., Yen, T., & Sung, F. (2016) · Retina · doi:10.1097/iae.0000000000001011 · Cited by 20
Genetic Association Analysis of Drusen Progression
Hoffman, J., van Grinsven, M. J. J. P., Li, C., Brantley, M. A., McGrath, J. A., Agarwal, A., Scott, W. K., Schwartz, S. G., Kovach, J. L., Pericak‐Vance, M. A., et al. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-18571 · Cited by 18
Miyake, M., Yamashiro, K., Tamura, H., Kumagai, K., Saito, M., Sugahara-Kuroda, M., Yoshikawa, M., Oishi, M., Akagi-Kurashige, Y., Nakata, I., et al. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-16020 · Cited by 17
Instability in X chromosome inactivation patterns in AMD: a new risk factor?
Bajić, V., Spremo‐Potparević, B., Mandušić, V., Milićević, Z., & Živković, L. (2013) · Medical Hypothesis Discovery & Innovation in Ophthalmology · Cited by 13
Kaszubski, P. A., Ami, T. B., Saade, C., Nabati, C., Kumar, V., Santos, A. R., da Silva, R. M., Cachulo, M. L., Cunha-Vaz, J. G., & Smith, R. T. (2017) · International Ophthalmology · doi:10.1007/s10792-017-0485-7 · Cited by 12
Pharmacogenetics and nutritional supplementation in age-related macular degeneration
Schwartz, S., Hampton, B., & Kovach, J. (2015) · Clinical Ophthalmology · doi:10.2147/opth.s84155 · Cited by 9
Age-related macular degeneration and cataract surgery
Rosen, E. S. (2014) · Journal of Cataract & Refractive Surgery · doi:10.1016/j.jcrs.2013.11.022 · Cited by 7
NAT2 STUDY: OMEGA-3 LEVELS IN RED BLOOD CELLS MEMBRANES CORRELATES THE PREVENTIVE EFFECT
Souied, E. H., Delcourt, C., Querques, G., Merle, B. M. J., Smith, T., & Benlian, P. (2013) · Investigative Ophthalmology & Visual Science · Cited by 6
Cited by
Age-related macular degeneration
Fleckenstein, M., Keenan, T. D. L., Guymer, R. H., Chakravarthy, U., Schmitz-Valckenberg, S., Klaver, C. C., Wong, W. T., & Chew, E. Y. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00265-2 · Cited by 978
Age-related macular degeneration
Guymer, R. H., & Campbell, T. G. (2023) · The Lancet · doi:10.1016/s0140-6736(22)02609-5 · Cited by 502
The complement system in age-related macular degeneration
Armento, A., Ueffing, M., & Clark, S. J. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03796-9 · Cited by 258
Lee, K. S., Lin, S., Copland, D. A., Dick, A. D., & Liu, J. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02088-0 · Cited by 150
Implications of genetic variation in the complement system in age-related macular degeneration
de Jong, S., Gagliardi, G., Garanto, A., de Breuk, A., Lechanteur, Y. T. E., Katti, S., van den Heuvel, L. P., Volokhina, E. B., & den Hollander, A. I. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100952 · Cited by 71
Self-citation
Metadata
- Authors
- Heesterbeek, T. J., Lorés‐Motta, L., Hoyng, C. B., Lechanteur, Y. T. E., & den Hollander, A. I.
- Venue
- Ophthalmic and Physiological Optics
- Published
- 2020-02-25
- Volume
- 40
- Issue
- 2
- Pages
- 140-170
- ISSN
- 0275-5408 (ISSN-L)
- 1475-1313
- OpenAlex
- W3008861510
- Cited by
- 392
- References
- 235
- FWCI
- 31.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.